Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes.

de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, Ophoff RA.

PLoS One. 2012;7(6):e39498. doi: 10.1371/journal.pone.0039498. Epub 2012 Jun 27.

2.

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.

Ruderfer DM, Charney AW, Readhead B, Kidd BA, Kähler AK, Kenny PJ, Keiser MJ, Moran JL, Hultman CM, Scott SA, Sullivan PF, Purcell SM, Dudley JT, Sklar P.

Lancet Psychiatry. 2016 Apr;3(4):350-7. doi: 10.1016/S2215-0366(15)00553-2. Epub 2016 Feb 23.

3.

Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain.

Richards AL, Jones L, Moskvina V, Kirov G, Gejman PV, Levinson DF, Sanders AR; Molecular Genetics of Schizophrenia Collaboration (MGS); International Schizophrenia Consortium (ISC), Purcell S, Visscher PM, Craddock N, Owen MJ, Holmans P, O'Donovan MC.

Mol Psychiatry. 2012 Feb;17(2):193-201. doi: 10.1038/mp.2011.11. Epub 2011 Feb 22.

4.

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.

Kumarasinghe N, Beveridge NJ, Gardiner E, Scott RJ, Yasawardene S, Perera A, Mendis J, Suriyakumara K, Schall U, Tooney PA.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1483-503. doi: 10.1017/S1461145713000035. Epub 2013 Feb 27.

PMID:
23442539
5.

Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population.

Yu H, Bi W, Liu C, Zhao Y, Zhang JF, Zhang D, Yue W.

J Psychiatr Res. 2014 Mar;50:73-8. doi: 10.1016/j.jpsychires.2013.11.014. Epub 2013 Dec 13.

PMID:
24365204
6.

Searching joint association signals in CATIE schizophrenia genome-wide association studies through a refined integrative network approach.

Jia P, Zhao Z.

BMC Genomics. 2012;13 Suppl 6:S15. doi: 10.1186/1471-2164-13-S6-S15. Epub 2012 Oct 26.

7.

Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.

Duarte RRR, Troakes C, Nolan M, Srivastava DP, Murray RM, Bray NJ.

Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):806-14. doi: 10.1002/ajmg.b.32445. Epub 2016 Mar 22.

8.

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.

Le Hellard S, Mühleisen TW, Djurovic S, Fernø J, Ouriaghi Z, Mattheisen M, Vasilescu C, Raeder MB, Hansen T, Strohmaier J, Georgi A, Brockschmidt FF, Melle I, Nenadic I, Sauer H, Rietschel M, Nöthen MM, Werge T, Andreassen OA, Cichon S, Steen VM.

Mol Psychiatry. 2010 May;15(5):463-72. doi: 10.1038/mp.2008.110. Epub 2008 Oct 21.

PMID:
18936756
9.
10.

Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility.

Yamada K, Hattori E, Iwayama Y, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Yoshikawa T.

Schizophr Res. 2015 Oct;168(1-2):444-9. doi: 10.1016/j.schres.2015.08.018. Epub 2015 Aug 29.

PMID:
26324334
11.

SZGR 2.0: a one-stop shop of schizophrenia candidate genes.

Jia P, Han G, Zhao J, Lu P, Zhao Z.

Nucleic Acids Res. 2017 Jan 4;45(D1):D915-D924. doi: 10.1093/nar/gkw902. Epub 2016 Oct 12.

12.

Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls.

Maschietto M, Silva AR, Puga RD, Lima L, Pereira CB, Nakano EY, Mello B, Gama CS, Belmonte-de-Abreu P, Carraro DM, Palha JA, Brentani H.

Psychiatry Res. 2012 Dec 30;200(2-3):1018-21. doi: 10.1016/j.psychres.2012.04.030. Epub 2012 May 26.

PMID:
22633013
13.

Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia.

Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF, Sokoloff P.

Mol Psychiatry. 2000 Sep;5(5):558-62.

PMID:
11032392
14.

Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes.

de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA; PGC Schizophrenia (GWAS) Consortium.

Eur J Hum Genet. 2012 Sep;20(9):1004-8. doi: 10.1038/ejhg.2012.38. Epub 2012 Mar 21.

15.

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.

Choi KH, Higgs BW, Weis S, Song J, Llenos IC, Dulay JR, Yolken RH, Webster MJ.

BMC Psychiatry. 2009 Sep 16;9:57. doi: 10.1186/1471-244X-9-57.

16.

Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.

Ovenden ES, Drögemöller BI, van der Merwe L, Chiliza B, Asmal L, Emsley RA, Warnich L.

Pharmacogenomics. 2017 Jan;18(2):105-120. doi: 10.2217/pgs-2016-0108. Epub 2016 Dec 19.

PMID:
27992301
17.

Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia.

Kuzman MR, Medved V, Terzic J, Krainc D.

J Psychiatr Res. 2009 Sep;43(13):1073-7. doi: 10.1016/j.jpsychires.2009.03.005. Epub 2009 Apr 8.

PMID:
19358997
18.

Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.

Kunii Y, Hyde TM, Ye T, Li C, Kolachana B, Dickinson D, Weinberger DR, Kleinman JE, Lipska BK.

Mol Psychiatry. 2014 Feb;19(2):192-9. doi: 10.1038/mp.2012.174. Epub 2013 Jan 8.

PMID:
23295814
19.

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL.

Arch Gen Psychiatry. 2012 Sep;69(9):904-12.

20.

Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.

Greenbaum L, Alkelai A, Rigbi A, Kohn Y, Lerer B.

Mov Disord. 2010 Dec 15;25(16):2809-17. doi: 10.1002/mds.23377.

PMID:
20939080

Supplemental Content

Support Center